Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 729 of 1,261
  1. US 9156891

    Vaccines and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  2. US 9157069

    Method of producing pancreatic hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  3. US 9157916

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  4. US 9157121

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  5. US 9156906

    Glycopeptides and methods of making and using them

    The Regents of the University of California · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  6. US 9156853

    AKT inhibitor compounds for treatment of cancer

    ALMAC DISCOVERY LIMITED · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  7. US 9156886

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  8. US 9156867

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  9. US 9156837

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  10. US 9156818

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  11. US 9156787

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  12. US 9156786

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  13. US 9155798

    Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

    Regents of the University of Minnesota · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  14. US 9155759

    Heterochain aliphatic poly-N-oxide copolymers and vaccinating agents and drugs based thereon

    OBCHTCHESTVO S OGRANITCHENNOI OTVESTVENNOSTYOU “NPO PETROVAKS FARM” · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  15. US 9155797

    Oligomer-cannabinoid conjugates

    Nektar Therapeutics · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  16. US 9155703

    Method and process for the production of multi-coated recognitive and releasing systems

    The Board of Regents of the University of Texas System · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  17. US 9155778

    Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  18. US 9155775

    Process for manufacturing glatiramer acetate product

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  19. US 9156820

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  20. US 9156829

    Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  21. US 9156880

    Prodrug of an ice inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  22. US 9156890

    HCV vaccines and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  23. US 9155801

    Amino acid sequences which enhance peptide conjugate solubility

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  24. CA 2943376

    NEBULISATION D'IMMUNOGLOBULINE

    MEDIZINISCHE HOCHSCHULE HANNOVER [GB] · Granted Oct 8, 2015 · Expires Oct 3, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.